Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-067690
Filing Date
2025-07-14
Accepted
2025-07-14 13:36:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5538
  Complete submission text file 0001104659-25-067690.txt   7212
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Subject) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92230 | Film No.: 251121030
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 2/F, PALM GROVE HOUSE ROAD TOWN TORTOLA Virgin Islands, British 00000
Business Address
LUO DAWEI (Filed by) CIK: 0002077013 (see all company filings)

Type: SCHEDULE 13G